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Abstract
Background: Overviews of systematic reviews attempt to systematically retrieve and summarise the results of multiple
systematic reviews into a single document. Methods for conducting, interpreting and reporting overviews of reviews
are in their infancy. To date, there has been no systematic review or evidence map examining the range of methods
for overviews nor of the evidence for using these methods. The objectives of the study are to develop and populate a
framework of methods that have or may be used in conducting, interpreting and reporting overviews of systematic
reviews of interventions (stage I); create an evidence map of studies that have evaluated these methods (stage II);
and identify and describe unique methodological challenges of overviews.
Methods: The research will be undertaken in two stages. For both stages, we plan to search methods collections
(e.g. Cochrane Methodology Register, Meth4ReSyn library, AHRQ Effective Health Care Program) to identify
eligible studies. These searches will be supplemented by searching reference lists and citation searching. Stage I:
Methods used in overviews will be identified from articles describing methods for overviews, methods studies
examining a cross section/cohort of overviews, guidance documents and commentaries. The identified methods
will populate a framework of available methods for conducting an overview. Two reviewers will independently
code included studies to develop the framework. Thematic analysis of the coded data will be used to categorise
and describe methods. Stage II: Evaluations of the performance of methods will be identified from systematic
reviews of methods studies and methods studies. Evaluations will be described and mapped to the framework of
methods identified in stage I.
Discussion: The results of this process will be useful for mapping of methods for overviews of systematic reviews,
informing guidance and identifying and prioritising method research in this field.
Keywords: Evidence map, Overviews of systematic reviews, Evidenced-based methods
Background
Overviews of systematic reviews (or umbrella reviews)
attempt to systematically retrieve and summarise the
results of multiple systematic reviews into a single
document [1]. The number of published overviews of
systematic reviews (henceforth termed overviews) has
increased steadily in recent years, in part due to the
proliferation of systematic reviews [2]. Methods for
conducting, interpreting and reporting overviews are
in their infancy [2]. To date, there has been no sys-
tematic review or evidence map examining the range
of methods for overviews (particularly those which are
unique to overviews) nor of the evidence for using
these methods.
In general, the steps for undertaking an overview
mirror those of a systematic review, with many of the
methods used in systematic reviews being directly trans-
ferrable to overviews (e.g. independent study selection and
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data extraction) [3]. However, there are unique features of
overviews that require the use of different or additional
methods, for example, methods for assessing the quality
or the risk of bias in systematic reviews; dealing with the
inclusion of the same trial in multiple systematic reviews;
dealing with out-of-date systematic reviews; and dealing
with discordant results across systematic reviews [2].
Evidence maps provide a systematic method for mapping
the evidence on a particular topic, with the resulting map
facilitating identification of gaps in the literature [4, 5].
Bragge [6] defines evidence mapping as describing the
yield, design and characteristics of research in broad topic
areas, in contrast to systematic reviews, which usually
address narrowly focused research questions. Evidence
mapping has been primarily used to map the evidence for
healthcare interventions [7, 8]; however, the approach may
also be usefully applied for mapping the evidence on other
topics. For example, evidence mapping may be useful for
collating evidence on the range and performance of
research methods. To our knowledge, evidence mapping
has yet to be applied in this way [5].
Where possible, methodological guidance for conducting
overviews should be based on empirical research; that is,
based on methods that have been evaluated and shown to
have better performance [9]. It is therefore timely to sys-
tematically review and map the available methods literature
to determine where there are gaps or areas of uncertainty
and hence what methods research should be undertaken as
a priority. We will apply the evidence mapping approach
to studies evaluating the methods for conducting, inter-
preting and reporting overviews of systematic reviews
of interventions.
The objectives of this study are to develop and popu-
late a framework of methods that have been used, or
may be used, in conducting, interpreting and reporting
overviews of systematic reviews of interventions (stage I);
(2) create an evidence map of studies that have evaluated
these methods (stage II); and (3) identify and describe
unique methodological challenges of overviews.
Methods/design
The methods used in this study are based on published
methods for mapping the evidence in broad content
areas [4, 6, 10–13]. Methods for developing an evidence
map involve several steps, namely, defining a topic and
specific questions to be answered by the evidence map;
searching for and selecting relevant studies; and reporting
on the yield and study characteristics.
Our mapping study will involve two stages. In stage I,
we will use the following sources to identify and describe
methods that have been used or recommended for use
in overviews: articles describing methods for overviews,
methods studies that have described the characteristics
of a cross section or cohort of overviews; guidance
documents for conducting overviews; and commentaries
or editorials. The identified methods will populate a
framework of methods relating to the steps involved in
conducting an overview (e.g. defining objectives, search-
ing for systematic reviews, selecting studies). The second
stage will involve the development of an evidence map
of studies that have evaluated any of the identified
methods (stage II). The steps involved in these stages
are depicted in Fig. 1. The evidence map will facilitate
identification of methods that have had little or no
evaluation.
We have used the Preferred Reporting Items for System-
atic reviews and Meta-Analyses Protocols (PRISMA-P)
[14] to develop this protocol. The PRISMA-P checklist
was developed for the preparation of protocols of system-
atic reviews that summarise aggregate data from studies,
particularly the evaluations of the effects of interventions,
and therefore, not all PRISMA-P items were applicable
(Additional file 1). We did not register our evidence
map on PROSPERO, the international prospective
register of systematic reviews (http://www.crd.york.ac.uk/
PROSPERO/), since reviews of ‘methodological issues’
do not met the inclusion criteria for this registry (as
specified 29 June 2015).
Search methods
Several sources will be searched to identify available
methods (stage I) and studies that have evaluated the
performance of those methods (stage II). We will under-
take searches of the following methods collections:
Cochrane Methodology Register, Meth4ReSyn library,
the Scientific Resource Center Methods library of the
AHRQ Effective Health Care Program, and Cochrane
Colloquium abstracts. In addition, we will undertake a
search of Ovid MEDLINE from 2000 onwards. We will
use variations of the following search terms: overview,
umbrella reviews, overviews of reviews, overviews of
systematic reviews, meta-review or review of reviews
(Additional file 2).
We will conduct purposive searches to locate evalua-
tions of the methods we have identified, where the above
searches are unlikely to have located these evaluations.
For example, although searching for systematic reviews
is a fundamental step of overviews, there are other pur-
poses aside from overviews (e.g. developing guidelines)
for which retrieving systematic reviews is necessary.
Therefore, papers describing the development and evalu-
ation of search strategies for systematic reviews may rea-
sonably not have mentioned ‘overviews’ (or its synonyms)
and thus would not be identified in the searches we
describe above. Details of these additional search strategies
will be documented and reported.
Given the potential difficulties in locating methods
literature on overviews, we will supplement our searches
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by examining the reference lists of all included articles
and undertaking citation searches of seminal papers using
Google Scholar, Scopus and Web of Science. All three of
these databases will be searched for citations because
searches run in each database have been shown to return
unique material [15]. In addition, as part of a related re-
search project to develop a search strategy to identify
overviews in MEDLINE, we set aside any methods papers
that we identified through screening citations [16]. Finally,
we will contact relevant experts in the field to help identify
additional methods papers.
Eligibility criteria
Separate eligibility criteria will be applied for stages I
and II of the development of the evidence map (Fig. 1).
Stage I: populating the framework—identification of
methods used in overviews of systematic reviews of
interventions
Inclusion criteria:
i) Articles describing methods for overviews
ii) Studies examining methods used in a cross section
or cohort of overviews
iii)Guidance (e.g. handbooks and guidelines) for
undertaking overviews
iv)Commentaries or editorials that discuss methods for
overviews
Exclusion criteria:
i) Articles published in languages other than English
ii) Studies describing methods for network meta-
analysis
iii)Articles exclusively about methods for overviews of
other review types (i.e. not of interventions)
If necessary, the framework (stage I) will be further
refined to include methods identified from studies in
stage II, if these have not already been identified in
stage I.
Stage II: populating the evidence map—identification of
evaluations of methods for overviews of systematic
reviews of interventions
Inclusion criteria:
i) Systematic reviews of methods studies that have
evaluated methods for overviews
ii) Methods studies that have evaluated methods for
overviews
Exclusion criteria:
i) Articles published in languages other than English
ii) Methods studies that have evaluated methods for
network meta-analysis
Stages in the development 
of the Evidence Map
Eligibility criteria Sources Search Methods Analysis and Output
Stage I                                   









• Articles describing 
methods for overviews            
• Studies examining a 
cohort or cross section 
of overviews                            
•  Guidance documents                        
• Commentaries or 
editorials                                  
• Expert opinion   
• Methods collections                                    
• MEDLINE                                      
• Reference checking                                  
• Citation searching                   
• Expert consultation                    
• Qualitative analysis to 
identify and describe 
unique methods; and           
• Populate the 
framework with 
identified methods
Stage II                               









• Systematic reviews of 
studies evaluating 
methods                           
• Methods studies 
evaluating methods
• Methods collections                                    
• MEDLINE                                      
• Reference checking                                  
• Citation searching                   
• Expert consultation                    
Populate the evidence 
map with evaluations of 
methods and identify 
gaps
Fig. 1 Stages in the development of an evidence map of overview methods
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In cases where we identify systematic reviews in
which the search for studies was conducted before
2013, we will search for more recent methods stud-
ies and include the results of these in the evidence
map, in addition to including the results of the sys-
tematic review.
We plan to populate the evidence map with evalua-
tions of methods that are different or additional to those
required to undertake a systematic review of primary
research. For example, methods for screening articles for
inclusion in an overview (e.g. whether one or more re-
viewers are required) do not differ to those used in
undertaking a systematic review of primary research, so
would not be included. However, evaluations of methods
used to assess the quality or risk of bias of systematic re-
views are of relevance to overviews, and not systematic
reviews of primary research, and so would be included.
It may be the case that methods have been evaluated in
the context of other ‘overview’ products, such as guide-
lines, and if these methods are of relevance to overviews,
they will be included.
The eligibility criteria will be pilot tested by three
independent reviewers on a sample of articles retrieved
from the search to ensure consistent application.
Study selection
Citations retrieved from the searches will be imported
into EndNote. Duplicates will be identified and removed.
Two reviewers will independently review titles and ab-
stracts for their potential inclusion against the selection
criteria. Full-text articles will be retrieved when both
reviewers agree that inclusion criteria have been met or
when there is uncertainty. Two reviewers will then
independently assess the articles for inclusion; any
disagreement will be resolved by discussion or by ar-
bitration of a third reviewer. In instances where there
is limited or incomplete information regarding a study’s
eligibility (e.g. when only an abstract is available), the
authors will be contacted to request the full text or
further details.
Assessment of the risk of bias of evaluation studies (stage II)
There is no tool available to assess the risk of bias of
studies that have evaluated methods (i.e. studies meet-
ing the criteria for stage II). We will therefore report
characteristics of the evaluation studies that may
plausibly be associated with bias and have been used
in other methodology reviews (e.g. [17–19]). These
characteristics will include study design, method to
select the cohort of studies included in the evaluation,
process used to extract data and existence of a proto-
col. For systematic reviews of methods studies, we
will use a tool to assess the risk of bias in systematic
reviews (ROBIS) [20].
Data extraction, data coding and analysis
Developing the coding framework
The coding framework will be developed using an iterative
process. Two reviewers (CL, SB) will independently code
three articles using a simple framework comprised of codes
representing the main steps in conducting an overview as
outlined in the Cochrane Handbook (e.g. specifying eligi-
bility criteria, data extraction) [21]. Additional codes will
be generated inductively by the two reviewers from the text
of the three articles. The independently developed frame-
works will then be compared and combined into a single
integrated framework. The resulting framework will be
reviewed by all authors, then tested on three further arti-
cles purposively selected to reflect the diversity of article
types (i.e. study examining methods in a cohort of over-
views, guidance, editorial) included at stage I. Further re-
finements will be discussed and agreed by all authors. The
preliminary framework of parent and illustrative child
codes, with descriptions for interpreting each code, is
presented in Table 1.
Stage I: populating the framework
Data will be coded from articles meeting the inclusion
criteria of stage I using NVivo software. Coded data will
be analysed thematically to further refine and populate
the framework with descriptions of each method. This
thematic analysis will be used to (1) determine the most
appropriate categorisation of methods (i.e. the final
structure and terminology used in the framework); (2)
determine whether or not methods are distinct (i.e. iden-
tifying whether methods described using different ter-
minology are indeed different and vice versa); and (3)
write a description of each method by synthesising key
concepts across included studies. In addition, data will
be coded to identify the type of paper (article describing
method for overviews, cohort/cross-sectional; commentary
or editorial; guidance document); noted advantages/disad-
vantages of the method; examples of use; at which step in
the overview process the method is used; and unique
methodological considerations in conducting overviews.
Stage II: populating the evidence map
We plan to extract the following data from methods
evaluation studies using a data extraction form: charac-
teristics of the article (e.g. publication year, journal);
characteristics of the study (study design, type of sample
selection (e.g. random, consecutive, others), process to
extract data, existence of a protocol); primary objec-
tive(s); secondary objective(s); methods evaluated for pri-
mary objective; evaluation analysis methods; and the
quantitative results relating to the primary objective.
Coding and data extraction for both stages of the study
will be undertaken independently by two reviewers. We
anticipate that it will be difficult to pre-specify response
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Table 1 Coding framework for methods used in overviews of systematic reviews of interventions (stage I)
Parent code Cues for the coder (description of the code)
Child code
1. Attributes of the study Information about the study being coded; includes codes for the purpose and aims
and methods of the study.
2. Definition of an overview Information about the concept and origins of overviews; includes codes for
definitions, terminology, rationale and key references for overviews.
3. Terminology for overviews Description of the terms used for overviews (e.g. ‘review of reviews’). Terms used
in the title, abstract and body of the study are coded separately.
4. Methodological considerations (independent of the step
or stage of the overview)
Information about the challenges and decisions faced when planning the methods
of an overview. Considerations that are unique to overviews should be coded,
such as dealing with reviews that (a) overlap in scope, (b) use different methods
for assessing bias in included studies, (c) report different outcomes for similar
comparisons and (d) have discrepant findings for the same outcomes/comparisons.
4.a. Dealing with currency (or lack of currency) of reviews Considerations relating to whether a review is up-to-date and the implications of
including reviews with older search or publication dates.
4.b. Dealing with reviews of different methodological quality Considerations relating to the inclusion and interpretation of reviews assessed as
being at a high risk of bias (e.g. because of the methods used to identify and select
studies, synthesis approach). This may include discussion about exclusion of poorer
quality reviews, decisions to weight the findings of reviews based on risk of bias
and consideration of risk of bias when grading the evidence arising from a review.
4.c. Dealing with overlap (and differences in scope) Considerations related to dealing with reviews that include the same studies and
overlapping information/data from those studies. Methods relevant to dealing with
overlap may apply to one or more steps/stages of the review (e.g. Population,
Intervention, Comparison, Outcome (PICO), assessment of quality of included
studies, summary and synthesis).
4.d. Dealing with gaps in review coverage Considerations relating to aspects of the overview question that have not been
addressed in reviews (e.g. particular comparisons, types of interventions, subgroups).
4.e. Dealing with missing (or loss of) information about
study characteristics
Considerations relating to the information available in reviews about the primary
study characteristics (PICO elements, study design). Reviewers report selected
information, focusing on that most relevant to their question. This may or may
not be congruent with the overview question, and the information may be
difficult to interpret out of context, resulting in loss of information.
4.f. Dealing with inconsistent or incomplete outcome
reporting across reviews
Considerations when reviews report different outcomes, outcome measures,
follow-up times, analyses or data from studies. This may include considerations
relating to loss of information if reviews that report unique outcome data are
excluded for other reasons (e.g. on the basis of date or quality).
4.g. Dealing with discrepant methods of quality appraisal
across reviews
Considerations when reviews use different methods to assess the risk of bias or
quality of included studies (e.g. Cochrane Risk of Bias tool [21], Newcastle-Ottawa
Quality Assessment Scale [23]).
4.h. Dealing with missing information from the synthesis
in reviews
Considerations relating to the type and nature of syntheses (including meta-analyses)
reported in the review. Reviewers conduct and report syntheses most pertinent
to their question, which may mean syntheses for particular subgroups, interventions
or outcomes are not available. Additional considerations may relate to missing
information about heterogeneity, sensitivity analyses or other analyses that
might be needed to interpret the results of a review.
4.i. Dealing with summary and synthesis of multi-faceted
interventions
Considerations relating to the summary and synthesis of findings for multi-faceted
interventions. Reviewers may take different approaches to synthesising findings for
multi-faceted interventions, driven in part by the question they aim to answer. For
example, they might examine potential additive effects of each intervention component
or they might decide that interventions are too heterogeneous for meaningful synthesis.
Across reviews, this can lead to quite different summaries and syntheses.
4.j. Dealing with discrepant findings across reviews Considerations when two or more reviews estimate or describe different effects
(quantitatively or qualitatively) based on similar studies or data. The findings of
two reviews that are similar in scope may differ (a) because their results are different
or (b) because the reviewers’ interpretation of the results is different. This node is
intended to capture the former.
4.k. Dealing with discrepant interpretation of similar
findings across reviews
Considerations when two or more reviews interpret similar results differently. The
findings of two reviews that are similar in scope may differ (a) because their results
are different or (b) because the reviewers’ interpretation of the results is different.
This node is intended to capture the latter.
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Table 1 Coding framework for methods used in overviews of systematic reviews of interventions (stage I) (Continued)
5. Methods (specific to step or stage of the overview) Identification, description and other information about the methods used to
conduct an overview, grouped by the steps (or stages) described in the
Cochrane Handbook [21].
5.a. Overall steps, sequence or stages Identification or summary of the key steps or stages involved in producing an
overview of reviews.
5.b. Specification of scope, questions, objectives Methods for determining, defining and reporting the scope of an overview;
includes factors that influence how broad or narrow questions should be, the
ways in which questions might be split (e.g. by condition, by population subgroup,
by intervention) and the implications of doing so. This node relates to the
specification of eligibility criteria but differs in that it covers conceptual issues
and the methodological implications of lumping/splitting.
5.c. Specification of eligibility criteria Methods for determining and specifying eligibility criteria (i.e. PICO); includes
restrictions on eligibility (e.g. publication status, year) that may be used to deal
with overlap; includes codes for outcome selection.
5.c.i. Outcome selection mechanisms Methods for specification and selection of outcomes. Note that while information
about outcome selection methods can be reported under eligibility criteria,
reviews are not necessarily excluded from the overview if they do not report a
specified outcome. Instead, the outcomes reported may determine inclusion in
the synthesis (or summary) of effects. In circumstances where reviews are included
irrespective of outcomes, information relating to outcome specification may need
to be coded under other relevant nodes (e.g. ‘Outcome selection mechanisms’).
5.c.ii. Decision rules for selecting a review from
multiple overlapping reviews
Methods for dealing with multiple reviews that include the same studies and
overlapping data from those studies. Several methods have been proposed to
deal with overlap and are represented in the subnodes. These include (a) the
review with the largest amount of studies, (b) most recent/up-to-date information,
(c) the highest quality studies, (d) most complete reporting, (e) by publication status,
(f) one review per author, (g) eliminate the review with the least amount of studies
and (h) ignore overlap.
5.d. Search methods Methods for searching for reviews in an overview; includes codes for specific
search filters used, such as those provided in PubMed.
5.e. Selection of reviews Methods for selecting reviews for inclusion in the overview, such as the use of
two reviewers to independently screen reviews for inclusion in the overview.
5.f. Data extraction and coding Methods for data extraction in an overview and coding of information from the
included reviews; includes codes for extracting data for subgroups, extracting data
from reviews versus trials, and methods used to select outcomes for extraction.
5.g. Assessment of risk of bias (methodological quality)
of primary studies included in the reviews
Methods for dealing with reviews that have used different methods or tools for
assessing risk of bias (or quality) of primary studies.
5.g. Assessment of risk of bias arising from the methods
of the review
Methods for assessing the risk of bias arising from the design, conduct and reporting
of reviews. Sometimes referred to as methodological quality of the review. Example
tools include ROBIS [20], A Measurement Tool to Assess Systematic Reviews
(AMSTAR) [24], National Institute for Health and Care Excellence (NICE) [25].
5.g. Assessment of the overall quality of the evidence
arising from the overview
Methods for assessing the overall quality of the evidence for each comparison/outcome
in the overview. These methods are likely to be the same as used for any synthesis
(e.g. Grades of Recommendation, Assessment, Development and Evaluation (GRADE) [26],
Scottish Intercollegiate Guidelines Network (SIGN) [27], FORM [28]) but may require
adaptation to synthesise evidence across reviews instead of primary studies. For example,
should the assessment of risk of bias in the included review be considered when
grading the evidence and, if so, how?
5.h. Synthesis Methods for analysing and synthesising the data in an overview; includes approaches
for dealing with meta-analyses with overlapping studies from different reviews
(i.e. those for the same comparison and outcomes), exploring heterogeneity, etc.
5.h.i. Quantitative synthesis Methods for quantitative synthesis in an overview; includes codes for synthesising
meta-analyses in an overview, exploring heterogeneity among included reviews,
considerations of how to include meta-analyses and how to include subgroup
analyses and synthesis and summary without meta-analysis.
5.h.ii. Synthesis and summary without meta-analysis Methods for synthesis and summary that do not include a meta-analysis
(e.g. plotting and tabulating data, vote counting).
5.i. Presentation and summary of findings Methods for presenting and summarising the findings of an overview. May include
methods for efficient depiction of the overlap of studies across included reviews,
methods for summarising findings when the same study is included in more
than one review, etc.
Lunny et al. Systematic Reviews  (2016) 5:4 Page 6 of 8
categories for each data extraction item due to the poten-
tial variability in the type of evaluations. Therefore, much
of the extracted data will be verbatim free text, which will
be categorised following discussion between the reviewers.
Discrepancies in extracted data will be discussed between
the reviewers until consensus is reached or by arbitration
of a third reviewer if required.
Data analysis
We will describe the evaluations that have been undertaken
and map these evaluations to the framework of methods
identified in stage I. The description of evaluations will in-
clude the yield and characteristics of the available evidence,
the use, advantages and disadvantages of each method and
a summary of the findings of the evaluations.
Discussion
Methods for conducting, interpreting and reporting over-
views are in their infancy. To date, there has been no sys-
tematic review or evidence map examining either the range
of methods for overviews or the evidence behind those
methods. We plan to use evidence mapping methods to de-
velop and populate a framework of methods used in con-
ducting, interpreting and reporting overviews of systematic
reviews of interventions (stage I) and create an evidence
map of studies that have evaluated these methods (stage II).
This will be a novel application of the evidence mapping
methodology in a context where, to our knowledge, this
method has not been used.
The results of the evidence map may influence the use
of particular methods in overviews, either directly or by
influencing guidance for overview methods. However,
perhaps the most notable use of the evidence map will
be in directing methods research to areas where there is
limited evidence for the methods that are being used.
Such a map may also be useful for national funding
agencies in considering what methods research should
be funded.
Strengths and limitations
We have developed a protocol to guide our research and
reduce post hoc decision making. Two reviewers will
undertake the screening, data coding and data extraction
of all methods studies. Searching for methodological
papers can prove very difficult in databases other than
specialist methodology collections, such as the Cochrane
Methodology Register and the Meth4ReSyn library [22].
In addition, while the coverage of two of the specialist
methodology collections extends beyond the health and
medical literature (Meth4ReSyn and Scientific Resource
Center Methods library), the focus of our search is within
health. These factors might mean that some relevant
methodology papers are missed. However, we have in-
cluded reference checking, citation searching and contact-
ing relevant experts in the field to minimise the impact of
these limitations.
Research status
At the time of submitting this protocol, we have under-
taken the searching and screening for stage I. Two re-
viewers have independently coded three methods papers
for stage I and developed an initial framework (Table 1).
During the peer-review process, we amended the inclu-
sion criteria to clarify that our focus was on methods for
overviews of systematic reviews of interventions. We
also revised our search strategies in response to sugges-
tions from the reviewer.
Summary
Our results will lead to an inventory of evaluation studies
of methods for overviews of systematic reviews of inter-
ventions. The evidence map will aid in the development
and implementation of methods for overviews which will
be relevant to a wide range of knowledge users, including
researchers, funders and journal editors. The evidence
map will help to prioritise the future research agenda in
this field.
Additional files
Additional file 1: PRISMA-P: recommended items to address in a
systematic review protocol. The Preferred Reporting Items for Systematic
reviews and Meta-Analyses Protocols (PRISMA-P) [14] was used to
develop this protocol. The PRISMA-P checklist was developed for the
preparation of protocols of systematic reviews that summarise aggregate
data from studies, particularly the evaluations of the effects of interventions,
and therefore, not all PRISMA-P items were applicable. (DOC 54 kb)
Additional file 2: Search strategies. The search strategies that will be
used to identify eligible studies. (DOC 24 kb)
Table 1 Coding framework for methods used in overviews of systematic reviews of interventions (stage I) (Continued)
5.j. Interpreting findings and drawing conclusions Methods for interpreting results and drawing conclusions in an overview.
5.k. Reporting Recommendations about the preferred reporting items for overviews, which may involve
using standards or guidelines for reporting overviews, checklists or reporting tools.
6. Pros and cons of method Known or anticipated benefits and disadvantages of using different methods in
an overview. These might relate to efficiency of production, utility of the
overview for decision makers and the validity of findings (bias in estimates
of intervention effects).
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